OpenAI has withdrawn previously announced revenue projections, signaling a $20B gap between actual and forecasted performance. This recalibration matters for healthcare AI vendors and implementers betting on large language models as core infrastructure for clinical decision support and EHR integration. The revision raises questions about LLM vendor stability and ability to deliver on promised capabilities for regulated healthcare environments. Organizations evaluating OpenAI partnerships for healthcare workflows should reassess timelines and have contingency plans. Consulting teams advising health systems on AI strategy need to factor in vendor execution risk more heavily than previously assumed.